Clinical Trial Update: The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring brief potent glutamatergic modulation for problem drinking in alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Alcohol Use Disorder | Phase 2 | Status: UNKNOWN